P.FangY
Eksperimentalnaya i Klinicheskaya Farmakologiya, 71(5), 13-16
Current anti-obesity pharmacotherapy includes 5 FDA-approved medications: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, and semaglutide (Table 2), as well as phentermine, which is approved only for short term use
This aggregate score was calculated using the following derived scores: Label Accuracy Score: 8.59, Non-Toxicity Score: 10.00
Footnotes Edited by Wang XL and Xu FM Proofread by Zhu LH References 1.Sikiric P, Petek M, Rucman R, Seiwerth S, Grabarevi Z, Rotkvi I, Jagi V, Turkovi B, Mildner B, Duvnjak M
Watts T, Berti I, Sapone A et al (2005) Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats